Number of patient participants needed for secondary approval of a new cancer drug.
Extending FDA-approved cancer drug indications requires high patient numbers, study finds
- Post author:
- Post published:September 29, 2023
- Post category:uncategorized
Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.
Subscribe To Us
By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy
© 2024 Diabetes Prevention Awareness Center.